Effect of metabolic inhibitors on interferon activity.
D000935:Antifungal Agents / Q000494:pharmacology*; D000963:Antimetabolites / Q000494:pharmacology*; D001681:Biological Assay; D046508:Culture Techniques; D003513:Cycloheximide / Q000494:pharmacology; D004279:DNA, Viral / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology*; D005467:Floxuridine / Q000494:pharmacology*; D007065:Idoxuridine / Q000494:pharmacology*; D007372:Interferons / Q000378:metabolism*; D015122:Mercaptopurine / Q000494:pharmacology*; D008937:Mitomycins / Q000494:pharmacology*; D009522:Newcastle disease virus; D011691:Puromycin / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000494:pharmacology*; D014764:Viral Proteins / Q000096:biosynthesis
D000935:Antifungal Agents; D000963:Antimetabolites; D004279:DNA, Viral; D008937:Mitomycins; D012333:RNA, Messenger; D013438:Sulfhydryl Compounds; D014764:Viral Proteins; D005467:Floxuridine; D003609:Dactinomycin; D011691:Puromycin; D007372:Interferons; D003513:Cycloheximide; D015122:Mercaptopurine; D007065:Idoxuridine